Compare ADMA Biologics Inc (ADMA) vs Snowflake Inc (SNOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Snowflake Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Snowflake Inc trades at $332.7 (market cap $116.01B). The key difference: Snowflake Inc is far larger — about 52.3× ADMA Biologics Inc's market cap, and Snowflake Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | SNOW | |
|---|---|---|
Market Cap | $2.22B | $116.01B |
Sector | Health | Technology |
52-Week High | $20.38 | $334.70 |
52-Week Low | $7.60 | $121.11 |
Enterprise Value | $2.29B | $115.82B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →
